Last week, we finally saw a proposed rule – “Telemedicine Prescribing of Controlled Substances When the Practitioner and the Patient Have not had a Prior In-Person Medical Evaluation” arrive at OMB. We expect that this proposed rule will avert the current end of telehealth prescribing flexibility on December 31, 2024. However, there remains significant risk [...]
Mental Health Groups Sent Letter on Schedule IIN Non-Narcotic Prescribing Mental health groups are pushing the agency to allow Schedule IIN non-narcotic drugs to be prescribed without an in-person visit. Those include stimulants used to treat attention-deficit/hyperactivity disorder. A coalition of mental health groups, including the American Psychiatric Association, the American Academy of Pediatrics [...]
The Alliance for Connected Care joined over 45 organizations in a statement to the Drug Enforcement Administration (DEA), requesting explicit guidance to the pharmacy community that the geography of a prescriber in relation to the patient or the pharmacy should not be a "red flag" when a prescription is a result of a telehealth [...]
Alliance Joins Letter With Mental Health Groups Calling on DEA for Continued Access to Treatments Through Telehealth
The Alliance worked to convene over 80 organizations in a letter to the Drug Enforcement Administration (DEA) calling on the DEA to finalize the special registration for telemedicine. The anticipated registration would enable a practitioner to deliver, distribute, dispense, or prescribe via telemedicine a controlled substance to a patient who has not been medically examined [...]